Arcturus Therapeutics (ARCT) EPS (2019 - 2026)
Arcturus Therapeutics (ARCT) EPS from Jun 30, 2019 to Mar 31, 2026. The TTM Arcturus Therapeutics (ARCT) EPS is -$2.80. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Arcturus Therapeutics (ARCT) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +11.35% |
| 5 Years TTM | -9.75% |
| All Time TTM | +3.04% |
Annual EPS change of Arcturus Therapeutics (ARCT)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.95 | -59.03% |
| 2025 | -$2.32 | -22.77% |
| 2024 | -$3.00 | +170.61% |
| 2023 | -$1.11 | -414.63% |
| 2022 | $0.35 | -104.56% |
| 2021 | -$7.72 | +180.36% |
| 2020 | -$2.75 | +60.45% |
| 2019 | -$1.72 | -15.50% |
| 2018 | -$2.03 | N/A |
Comparison Arcturus Therapeutics (ARCT) five years EPS CAGR with competitors
Arcturus Therapeutics (ARCT) five years EPS CAGR is -9.76%.